Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States-Reference-Cited by-同舟云学术

Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States

Published:2018-06 Issue:3 Volume:18 Page:220-228
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Stokes William A.,Amini Arya,Jackson Matthew W.,Plimpton S. Reed,Kounalakis Nicole,Kabos Peter,Rabinovitch Rachel A.,Rusthoven Chad G.,Fisher Christine M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS;Wapnir;J Natl Cancer Inst,2011

2. Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial;Donker;J Clin Oncol,2013

3. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial;Cuzick;Lancet Oncol,2011

4. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS trial;Warnberg;J Clin Oncol,2014

5. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation;McCormick;J Clin Oncol,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fractionation in adjuvant radiotherapy for invasive breast cancer and ductal carcinoma in situ in Ontario, Canada from 2009 to 2015;The Breast Journal;2019-09-12

2. A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study);Radiotherapy and Oncology;2019-02

3. Ductal carcinoma in situ (DCIS) breast cancer treated with 3-week accelerated hypofractionated whole-breast radiation therapy and concomitant boost;Journal of Radiation Oncology;2019-01-26